Compound Heterozygous Mutations of SACS in a Korean Cohort Study of Charcot-Marie-Tooth Disease Concurrent Cerebellar Ataxia and Spasticity.
Byung Kwon PiYeon Hak ChungHyun Su KimSoo Hyun NamAh Jin LeeDa Eun NamHyung Jun ParkSang Beom KimKi Wha ChungByung-Ok ChoiPublished in: International journal of molecular sciences (2024)
Mutations in the SACS gene are associated with autosomal recessive spastic ataxia of Charlevoix-Saguenay disease (ARSACS) or complex clinical phenotypes of Charcot-Marie-Tooth disease (CMT). This study aimed to identify SACS mutations in a Korean CMT cohort with cerebellar ataxia and spasticity by whole exome sequencing (WES). As a result, eight pathogenic SACS mutations in four families were identified as the underlying causes of these complex phenotypes. The prevalence of CMT families with SACS mutations was determined to be 0.3%. All the patients showed sensory, motor, and gait disturbances with increased deep tendon reflexes. Lower limb magnetic resonance imaging (MRI) was performed in four patients and all had fatty replacements. Of note, they all had similar fatty infiltrations between the proximal and distal lower limb muscles, different from the neuromuscular imaging feature in most CMT patients without SACS mutations who had distal dominant fatty involvement. Therefore, these findings were considered a characteristic feature in CMT patients with SACS mutations. Although further studies with more cases are needed, our results highlight lower extremity MRI findings in CMT patients with SACS mutations and broaden the clinical spectrum. We suggest screening for SACS in recessive CMT patients with complex phenotypes of ataxia and spasticity.
Keyphrases
- magnetic resonance imaging
- lower limb
- end stage renal disease
- newly diagnosed
- ejection fraction
- spinal cord injury
- early onset
- prognostic factors
- machine learning
- cerebral palsy
- contrast enhanced
- magnetic resonance
- computed tomography
- botulinum toxin
- risk factors
- deep learning
- genome wide
- fatty acid
- patient reported outcomes
- copy number
- photodynamic therapy
- mass spectrometry
- transcription factor
- diffusion weighted imaging